GNH USA

Europe — EMA

Lamivudin/Zidovudin Beta

GNH USA supplies Lamivudin/Zidovudin Beta (Zidovudine Lamivudine), a nucleoside reverse transcriptase inhibitor for HIV infection.

Zidovudine, Lamivudine

Request sourcing

1
Pack/s

What is Zidovudine, Lamivudine?

Zidovudine and Lamivudine, the active ingredients in Lamivudin/Zidovudin Beta, are nucleoside reverse transcriptase inhibitors presented as an oral tablet for adult patients. It treats human immunodeficiency virus (HIV) infection as part of combination antiretroviral therapy. GNH USA supplies Lamivudin/Zidovudin Beta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Zidovudine, Lamivudine used for?

Lamivudin/Zidovudin Beta is a nucleoside reverse transcriptase inhibitor used in the management of HIV infection. - Human immunodeficiency virus (HIV) infection: reduces viral replication when combined with other antiretrovirals, improving immune function. - HIV‑1 infection in adults: part of first‑line therapy to achieve sustained viral suppression. - HIV‑1 infection in adolescents: used under specialist supervision to control disease progression.

What are the side effects of Zidovudine, Lamivudine?

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Fatigue: general tiredness. - Anemia: reduced red blood cell count. - Neutropenia: lowered neutrophil levels. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Lactic acidosis: severe metabolic disturbance. - Hepatic steatosis: fatty liver disease. - Bone marrow suppression: pancytopenia risk. - Hypersensitivity reactions: rash, fever, eosinophilia. - Pancreatitis: inflammation of the pancreas. - Severe anemia: requiring transfusion.

What precautions apply to Zidovudine, Lamivudine?

Lamivudin/Zidovudin Beta should be used with careful monitoring and patient education. - Monitor blood counts: watch for anemia and neutropenia. - Assess liver function: check enzymes before and during therapy. - Evaluate renal function: adjust if impairment present. - Counsel on adherence: emphasize importance of consistent dosing. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Store at below 25°C: keep in the original pack, protect from moisture.

What does Zidovudine, Lamivudine interact with?

Lamivudin/Zidovudin Beta can interact with several medicines that affect its efficacy or safety. Major Interactions (Avoid): - Didanosine: increased risk of pancreatitis. - Stavudine: heightened mitochondrial toxicity. - Rifampin: reduces plasma concentrations of both agents. Moderate Interactions (Monitor Closely): - Efavirenz (NNRTI): may alter zidovudine levels. - Ritonavir (protease inhibitor): can affect lamivudine metabolism. - Alcohol: may exacerbate hepatotoxicity.

Frequently asked questions

What is Lamivudin/Zidovudin Beta used for?+
Lamivudin/Zidovudin Beta is a fixed‑dose combination of zidovudine and lamivudine used as part of antiretroviral therapy to treat human immunodeficiency virus (HIV) infection in adults and adolescents. It works together with other antiretroviral agents to suppress viral replication and improve immune function.
How does Zidovudine and Lamivudine work?+
Both drugs are nucleoside analogues that are converted inside cells to active triphosphate forms. These active metabolites compete with natural nucleosides for incorporation into the viral DNA chain by reverse transcriptase, causing premature termination of the DNA strand and blocking HIV replication.
What is the usual dose of Lamivudin/Zidovudin Beta?+
The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s age, weight, renal and hepatic function, and the overall antiretroviral regimen. Patients should follow the exact instructions provided by their healthcare professional.
Is Lamivudin/Zidovudin Beta safe during pregnancy or breastfeeding?+
Safety in pregnancy and lactation has not been fully established. The drug may be used if the potential benefits to the mother outweigh any possible risks to the fetus or infant, and this decision should be made by a qualified healthcare provider.
How do I order Lamivudin/Zidovudin Beta from GNH USA?+
Enquiries are submitted via the product page on gnh-usa.com, where you specify the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Lamivudin/Zidovudin Beta compare with other HIV drugs?+
This combination provides two nucleoside reverse transcriptase inhibitors in a single tablet, simplifying regimens compared with taking separate agents. It is often used as a backbone in combination with non‑nucleoside reverse transcriptase inhibitors or protease inhibitors, offering comparable efficacy to other NRTI backbones such as tenofovir/emtricitabine.
What are the storage requirements for Lamivudin/Zidovudin Beta?+
Store the tablets at or below 25 °C in their original packaging, protected from moisture and direct sunlight. Do not expose the product to excessive heat or humidity, and keep it out of reach of children.
How is Lamivudin/Zidovudin Beta administered?+
The medication is taken orally, usually with food or a glass of water, as directed by the prescribing clinician. Swallow the tablet whole; do not crush, chew, or split it unless specifically instructed by a healthcare professional.
What are the most serious risks associated with Lamivudin/Zidovudin Beta?+
Serious adverse events can include lactic acidosis, severe hepatic steatosis, bone‑marrow suppression leading to pancytopenia, and hypersensitivity reactions such as rash or fever. Patients should seek immediate medical attention if they experience unexplained fatigue, abdominal pain, rapid breathing, or signs of infection.
Who should not use Lamivudin/Zidovudin Beta?+
Individuals with known hypersensitivity to zidovudine, lamivudine, or any excipients in the tablet should avoid this medication. It is also contraindicated in patients with severe bone‑marrow suppression or uncontrolled liver disease, unless a specialist determines that benefits outweigh the risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Zidovudine, Lamivudine
Route
Oral Use
Manufacturer
Betapharm Arzneimittel Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU